In this issue:
- Margin status and survival outcomes after surgery
- Multimodal prehabilitation in breast cancer
- Factors associated with time to biopsy after abnormal mammography
- Breastfeeding reduces the risk of breast cancer
- Bisphosphonates and prevention of perimenopausal breast cancer recurrence
- Characteristics and disease outcomes in ERBB2-low early breast cancer
- Abemaciclib ± tamoxifen in endocrine-refractory HR+/HER2– MBC
- Atezolizumab in high-risk, HER2+ early breast cancer
- OS results with olaparib in the OlympiA phase III trial
- ctDNA and late recurrence in high-risk HR+/HER2– breast cancer
Please login below to download this issue (PDF)